Article

IntraLase launches fourth-generation laser

San Francisco-IntraLase Corp. introduced itsfourth-generation FS Laser, a system that allows for a 100%blade-free LASIK procedure, according to the company.

San Francisco-IntraLase Corp. introduced its fourth-generation FS Laser, a system that allows for a 100% blade-free LASIK procedure, according to the company.

Doubling the speed of the first laser used to create LASIK corneal flaps reduces the flap procedure time to less than 15 seconds, while maintaining the procedure's excellent safety profile and visual outcomes, the company said in a prepared statement.

"The fourth-generation FS Laser, which comes just 11 months after the introduction of our 30-kHz laser, demonstrates our commitment to the rapid development of our femtosecond technology," said Robert J. Palmisano, president and chief executive officer of IntraLase. "Our commitment to innovation is focused on the fast delivery of the laser's benefits to surgeons and patients."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.